Because the synergistic effect of chemo-immunotherapy has generated much interest as a new therapeutic strategy, mTOR signaling may be a potential therapeutic target for cancer therapy as a central regulator for tumor progression and immune evasion in tumor-bearing hosts. This evidence concerns the gene MTOR and cancer.